Hyperkalemia Clinical Trials

11 recruiting

Hyperkalemia Trials at a Glance

12 actively recruiting trials for hyperkalemia are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Shanghai, Paris, and Angers. Lead sponsors running hyperkalemia studies include AstraZeneca, Leiden University Medical Center, and AccurKardia, Inc..

Browse hyperkalemia trials by phase

Treatments under study

About Hyperkalemia Clinical Trials

Looking for clinical trials for Hyperkalemia? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperkalemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperkalemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

Hyperkalemia
AstraZeneca6,215 enrolled1 locationNCT07370194
Recruiting
Phase 2

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

Hyperkalemia
Vifor Pharma, Inc.32 enrolled37 locationsNCT05766839
Recruiting
Not Applicable

Hyperkalemia Quality Improvement Program (HK-QIP) Study

Hyperkalemia
AstraZeneca1,000 enrolled49 locationsNCT06884267
Recruiting
Phase 1Phase 2

Adding Urea to the Final Dialysis Fluid

HyperkalemiaMetabolic AcidosisDysequilibrium Syndrome+1 more
University of California, San Francisco20 enrolled1 locationNCT06366230
Recruiting
Not Applicable

Dietary Potassium Liberalization in Pre-Dialysis Patients

Chronic Kidney DiseaseHyperkalemia
University of Manitoba30 enrolled2 locationsNCT05090865
Recruiting
Phase 4

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

HypertensionChronic Kidney DiseasesHyperkalemia
University Medical Center Groningen44 enrolled1 locationNCT06256991
Recruiting
Phase 3

A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia

Hyperkalemia
Waterstone Pharmaceutical (Wuhan) Co., LTD.420 enrolled50 locationsNCT07251309
Recruiting

AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring

HyperkalemiaChronic Kidney Disease (Stage 3-4)
AccurKardia, Inc.50 enrolled1 locationNCT07210021
Recruiting

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

Chronic Kidney Disease(CKD)Hyperkalemia
Xiujuan Zang1,890 enrolled1 locationNCT06940414
Recruiting
Phase 4

Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4

Chronic Kidney DiseaseDiet ModificationHyperkalemia+1 more
Leiden University Medical Center16 enrolled1 locationNCT06365684
Recruiting
Not Applicable

Low-potassium Content Vegetables in Chronic Kidney Disease

the Recommended Target of Daily Vegetables IntakeRisk of Hyperkalemia
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation75 enrolled2 locationsNCT06428942
Recruiting
Phase 4

Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

Hyperkalemia
Nantes University Hospital525 enrolled16 locationsNCT04012138